Incyte Genomics
INCY
NASDAQ
IPO1993
about INCY
Incyte Genomics is a biopharmaceutical company focused on advancing innovative cancer treatments through precision medicine and oncology research, offering targeted therapies for patients with serious diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $85.78 | $86.94 | $84.54 | $16.90B | 1.90M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$2.09 | 66.34 | 14.53 | 43.63% | 33.32% | 0% |